Bicycle Therapeutics plc (BCYC)

Bicycle Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	648.33	879.52	526.42	339.15	438.68	135.99
Cash & Short-Term Investments	648.33	879.52	526.42	339.15	438.68	135.99
Cash Growth	-27.22%	67.07%	55.22%	-22.69%	222.58%	47.63%
Accounts Receivable	-	-	-	2.05	1	5.46
Other Receivables	67.26	35.65	24.04	19.16	10.91	9.18
Receivables	67.26	35.65	24.04	21.21	11.91	14.63
Prepaid Expenses	23.23	13.43	11.41	9.02	7.97	5.1
Total Current Assets	738.82	928.61	561.87	369.38	458.56	155.72
Property, Plant & Equipment	11.42	17.19	27.68	32.77	17.79	3.61
Other Long-Term Assets	13.71	11.07	5.79	8.46	3.45	1.82
Total Assets	763.95	956.87	595.34	410.61	479.79	161.15
Accounts Payable	12.65	15.79	13.05	6.47	2.72	1.37
Accrued Expenses	39.4	35.45	26.38	21.86	11.29	10.58
Current Portion of Leases	4.76	5.5	4.88	3.13	2.38	0.84
Current Unearned Revenue	12.26	10.19	24.98	20.42	19.27	10.14
Other Current Liabilities	0.2	0.3	0.26	1.47	0.57	0.21
Total Current Liabilities	69.28	67.23	69.54	53.34	36.24	23.13
Long-Term Debt	-	-	30.7	30.32	29.87	14.51
Long-Term Leases	0.98	3.99	9.38	10.89	12.08	0.43
Long-Term Unearned Revenue	74.12	91.47	110.22	41.46	52.07	25.02
Other Long-Term Liabilities	1.09	1.12	4.58	3.83	3.28	2.61
Total Liabilities	145.48	163.81	224.41	139.83	133.54	65.69
Common Stock	0.89	0.89	0.55	0.39	0.38	0.27
Additional Paid-In Capital	1,501	1,473	883.45	601.11	567.64	249.95
Retained Earnings	-879.6	-680.79	-511.76	-331.1	-218.38	-151.56
Comprehensive Income & Other	-3.47	0.12	-1.3	0.39	-3.39	-3.19
Total Common Equity	618.48	793.06	370.93	270.78	346.25	95.46
Shareholders' Equity	618.48	793.06	370.93	270.78	346.25	95.46
Total Liabilities & Equity	763.95	956.87	595.34	410.61	479.79	161.15
Total Debt	5.74	9.49	44.96	44.33	44.34	15.78
Net Cash (Debt)	642.58	870.03	481.47	294.83	394.34	120.22
Net Cash Growth	-26.96%	80.70%	63.30%	-25.24%	228.03%	33.24%
Net Cash Per Share	9.28	14.95	13.53	9.94	15.73	6.28
Filing Date Shares Outstanding	69.37	69.2	42.59	30.02	29.6	23.09
Total Common Shares Outstanding	69.31	69.06	42.43	29.87	29.58	21.09
Working Capital	669.54	861.38	492.33	316.04	422.32	132.59
Book Value Per Share	8.92	11.48	8.74	9.06	11.71	4.53
Tangible Book Value	618.48	793.06	370.93	270.78	346.25	95.46
Tangible Book Value Per Share	8.92	11.48	8.74	9.06	11.71	4.53
Machinery	18.92	16.53	16.91	16.24	7.11	5.97
Leasehold Improvements	11.71	10.9	11	10.74	0.81	0.38

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q